Clinical Trial Update: Esophageal Cancer Multimodal Prehabilitation Study [NA]

View source ↗

Summary

The Massachusetts General Hospital–sponsored esophageal cancer multimodal prehabilitation trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Neoplasms

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Esophageal Cancer, Esophageal Neoplasms | NA | Status: COMPLETED